Intelligence · Drug directory
EMA-Approved Drugs Directory
European Medicines Agency approved medicines with EPAR-derived status, INN profiles, and competitive intelligence links.
Quick answer
EMA-approved drugs: NovaPharmaNews tracks 931 pharmaceutical drugs in this segment. European Medicines Agency approved medicines with EPAR-derived status, INN profiles, and competitive intelligence links.
-
human papillomavirus vaccine [types 16, 18] (recombinant, adjuvanted, adsorbed)
CERVARIX
J07BM02 -
human papillomavirus vaccine [types 6, 11, 16, 18] (recombinant, adsorbed)
GARDASIL
J07BM01 -
hydroxycarbamide
HYDREA
L01XX05 -
idebenone
RAXONE
N06BX13 -
idecabtagene vicleucel
ABECMA
L01 -
imetelstat
RYTELO
L01XX80 -
imipenem
RECARBRIO
J01DH56 -
imlifidase
IDEFIRIX
L04AA -
imlunestrant
INLURIYO
L02BA -
inclisiran
LEQVIO Novartis Pharmaceuticals
C10AX -
indacaterol
ONBREZ Novartis Pharmaceuticals
R03AK -
inebilizumab
UPLIZNA
L04AA -
infliximab
INFLECTRA Pfizer Australia Pty Ltd
L04AB02 -
influenza vaccine (live attenuated, nasal)
FLUENZ TETRA
J07BB03 -
influenza vaccine (surface antigen, inactivated, adjuvanted)
FLUAD TETRA
J07BB02 -
influenza vaccine (surface antigen, inactivated, prepared in cell cultures)
FLUCELVAX
J07BB02 -
inotersen
TEGSEDI
N07 -
inotuzumab ozogamicin
BESPONSA Pfizer Australia Pty Ltd
L01FB01 -
insulin glulisine
APIDRA Sanofi-aventis Healthcare Pty Ltd
A10AB06 -
insulin human (rdna)
ACTRAPHANE
A10AD01 -
interferon beta-1a
BIFERONEX
L03AB07 -
ioflupane (123i)
CELSUNAX
V09AB03 -
ioflupane (123l)
STRIASCAN
V09AB03 -
iptacopan
FABHALTA Novartis Pharmaceuticals
L04A
Frequently asked questions
How many ema approved drugs are listed?
931 drug profiles match this regulatory segment in our published index.
Where does approval data come from?
Profiles combine FDA Drugs@FDA, EMA EPAR references, and regional authority feeds. See our data sources page for attribution.